YouMagic Developer Weimai Medical Secures Tens of Millions in Series B+ Financing Led by Xi Venture Capital and Suzhou Jinsheng Capital, with Keytone Capital as Exclusive Financial Advisor

In February 2025, WEMT, the developer of YOUMAGIC, completed a Series B+ financing round amounting to tens of millions of yuan. The round was led by Wuxi Capital Group and Suzhou Jinsheng Capital. Following an investment of over RMB 100 million from a leading domestic fund in December 2024, WEMT has secured additional capital injection from prominent state-owned investors within a short period. The proceeds from this round will be used to strengthen sales, expand market channels, enhance brand building, and sustain R&D investment in products. WinX Capital served as the exclusive long-term financial advisor.

Technological Innovation Builds Product Moats, While Talent Development Drives Corporate Growth. One of the lead investors in this financing round for WEMT, the R&D company behind YOUMAGIC, is Wuxi Capital Group, a state-owned venture capital firm. Wuxi Capital Group has long focused on strategic emerging industries such as biomedicine. Adhering to the investment philosophy of “investing in foresight, investing in the future, and investing in talent,” it prioritizes layout in future industries characterized by significant growth potential, high technical requirements, broad impact, and strong industry-driving capabilities.

As an enterprise recruited under the Wuxi Municipal Government’s talent introduction program, the YOUMAGIC technical team has jointly established the “Energy Medicine Engineering Research Center” with the Tsinghua University Wuxi Applied Technology Research Institute, bringing together a large pool of interdisciplinary talents needed by the industry. WEMT, the R&D company behind YOUMAGIC, has also been deeply involved in Wuxi’s technological innovation and industrial development across multiple sectors, serving as one of the key engines driving the local industry toward high-end advancement. A representative from Wuxi Capital Group stated that WEMT earned the firm’s favor due to its influence in industrial development, innovative strength, and commercial potential.

Building on talent development, WEMT, the R&D company behind YOUMAGIC that is deeply committed to advancing its industrial layout and development philosophy, shares a high degree of alignment in investment logic with Suzhou Jinsheng Capital, another lead investor in this round, laying a solid foundation for their partnership. Guided by national industrial policies, Suzhou Jinsheng Capital focuses on investing in core sectors such as healthcare, prioritizing companies with unique competitive advantages while also valuing innovation.

WEMT, the developer of YOUMAGIC, has been deeply engaged in the medical device industry for many years. Adhering to an R&D approach that integrates medicine and engineering, the company focuses on technological innovation and breakthroughs with high-performance radiofrequency energy systems as its core technology. In its development, WEMT has also demonstrated forward-looking strategic planning capabilities, establishing a rich product portfolio in both serious healthcare and consumer healthcare sectors. Its areas of expertise and strategic focus align with the investment direction of Suzhou Jinsheng Capital.

YOUMAGIC, WEMT’s flagship high-energy monopolar radiofrequency device for the consumer healthcare sector, leverages Tsinghua University-backed technology to achieve technical leadership. Featuring innovative advantages such as 100-millisecond flash pulse technology, dynamic pulse technology, and multi-layer cooling, it breaks through the limitations of traditional radiofrequency technologies, offering consumers a more comfortable, safer, and more effective differentiated option. Currently, including YOUMAGIC, multiple WEMT products have obtained Class III medical device certification from the NMPA. With accelerating commercialization efforts, the company’s comprehensive competitiveness and market expansion capabilities have earned the trust of Suzhou Jinsheng Capital.

Investors stated that Suzhou Jinsheng Capital will integrate resources to accelerate WEMT’s innovation and commercialization, while also facilitating the upgrading of the medical industry.A representative from WEMT, the developer of YOUMAGIC, stated, with the closing of this financing round, the company will accelerate its product commercialization strategy with support from multiple investors. It will continue to adhere to the path of integrating medicine and engineering, advance product R&D and technological innovation, be driven by addressing genuine market needs, provide users with higher-quality products, and accelerate the development of a modern industrial system through deep collaboration with various capital partners and local industries.

Zhao Qian’ao, Head of Consumer Healthcare & Interdisciplinary Fields at WinX Capital, stated: WEMT, the developer of YOUMAGIC, draws on decades of technological expertise accumulated at Tsinghua University and has carved out a successful path in medical-engineering integrated innovation. It is particularly commendable that the company has recently secured cross-endorsements from various institutions, including state-owned capital, market-oriented investors, and strategic industry partners. With the diverse resources introduced by these investors, we believe WEMT’s business will accelerate its growth further. WinX Capital is honored to serve as the exclusive long-term financial advisor, continuing to contribute to WEMT’s capital journey.